OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Depicting HIV-1 Transcriptional Mechanisms: A Summary of What We Know
Antoine Dutilleul, Anthony Rodari, Carine Van Lint
Viruses (2020) Vol. 12, Iss. 12, pp. 1385-1385
Open Access | Times Cited: 42

Showing 1-25 of 42 citing articles:

The Current Status of Latency Reversing Agents for HIV-1 Remission
Anthony Rodari, Gilles Darcis, Carine Van Lint
Annual Review of Virology (2021) Vol. 8, Iss. 1, pp. 491-514
Open Access | Times Cited: 99

In Vivo Dynamics of the Latent Reservoir for HIV-1: New Insights and Implications for Cure
Janet D. Siliciano, Robert F. Siliciano
Annual Review of Pathology Mechanisms of Disease (2021) Vol. 17, Iss. 1, pp. 271-294
Open Access | Times Cited: 61

Infectious RNA: Human Immunodeficiency Virus (HIV) Biology, Therapeutic Intervention, and the Quest for a Vaccine
Yasemin van Heuvel, Stefanie Schatz, Jamila Franca Rosengarten, et al.
Toxins (2022) Vol. 14, Iss. 2, pp. 138-138
Open Access | Times Cited: 36

HIV-1 Vpr Functions in Primary CD4+ T Cells
Carlos Alberto Vanegas-Torres, Michael Schindler
Viruses (2024) Vol. 16, Iss. 3, pp. 420-420
Open Access | Times Cited: 6

Combined noncanonical NF-κB agonism and targeted BET bromodomain inhibition reverse HIV latency ex vivo
Shane D. Falcinelli, Jackson J. Peterson, Anne‐Marie W. Turner, et al.
Journal of Clinical Investigation (2022) Vol. 132, Iss. 8
Open Access | Times Cited: 27

Genome-wide CRISPR screens identify combinations of candidate latency reversing agents for targeting the latent HIV-1 reservoir
Weiwei Dai, Fengting Wu, Natalie F. McMyn, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 667
Open Access | Times Cited: 27

Defective HIV-1 genomes and their potential impact on HIV pathogenesis
Jeffrey Kuniholm, Carolyn Coote, Andrew J. Henderson
Retrovirology (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 26

Breaking the Silence: Regulation of HIV Transcription and Latency on the Road to a Cure
Natasha N. Duggan, Tatjana Dragic, Sumit K. Chanda, et al.
Viruses (2023) Vol. 15, Iss. 12, pp. 2435-2435
Open Access | Times Cited: 13

The nuclear pore protein NUP98 impedes LTR-driven basal gene expression of HIV-1, viral propagation, and infectivity
Kumaraswami Chintala, Sriram Yandrapally, Warisha Faiz, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5

Heparanase, a host gene that potently restricts retrovirus transcription
Brandon Waxman, K. Salka, Uddhav Timilsina, et al.
mBio (2025)
Open Access

Nuclear retention of unspliced HIV-1 RNA as a reversible post-transcriptional block in latency
Alexandra Dorman, Maryam Bendoumou, Aurelija Valaitienė, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access

NF-κB-Driven HIV-1 Gene Expression in Human Cells Is Independent of Poly(ADP-ribose) polymerase-1 Function.
Denisse A. Gutiérrez, Manuel Llano
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access

Forging a Functional Cure for HIV: Transcription Regulators and Inhibitors
Sonia Mediouni, Shuang Lyu, Susan M. Schader, et al.
Viruses (2022) Vol. 14, Iss. 9, pp. 1980-1980
Open Access | Times Cited: 19

DNA topoisomerase 1 represses HIV-1 promoter activity through its interaction with a guanine quadruplex present in the LTR sequence
María José Lista, Anne-Caroline Jousset, Mingpan Cheng, et al.
Retrovirology (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 8

Shocking HIV-1 with immunomodulatory latency reversing agents
Anna Kula, Anthony Rodari, Gilles Darcis, et al.
Seminars in Immunology (2021) Vol. 51, pp. 101478-101478
Open Access | Times Cited: 18

Role of long noncoding RNA in regulating HIV infection—a comprehensive review
Noa Amir, Ran Taube
mBio (2024) Vol. 15, Iss. 2
Open Access | Times Cited: 2

Direct and indirect effects of CYTOR lncRNA regulate HIV gene expression
Alona Kuzmina, Lopamudra Sadhu, M. Hasanuzzaman, et al.
PLoS Pathogens (2024) Vol. 20, Iss. 4, pp. e1012172-e1012172
Open Access | Times Cited: 2

From Glycolysis to Viral Defense: The Multifaceted Impact of Glycolytic Enzymes on Human Immunodeficiency Virus Type 1 Replication
Naoki Kishimoto, Shogo Misumi
Biological and Pharmaceutical Bulletin (2024) Vol. 47, Iss. 5, pp. 905-911
Open Access | Times Cited: 2

A complex network of transcription factors and epigenetic regulators involved in bovine leukemia virus transcriptional regulation
Estelle Plant, Maxime Bellefroid, Carine Van Lint
Retrovirology (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 5

HIV-1 transcriptional modulation: novel host factors and prospective therapeutic strategies
Quentin M. R. Gibaut, Luisa Mori, Susana T. Valente
Current Opinion in HIV and AIDS (2023) Vol. 18, Iss. 5, pp. 264-272
Closed Access | Times Cited: 5

Solid Phase Synthesis and TAR RNA-Binding Activity of Nucleopeptides Containing Nucleobases Linked to the Side Chains via 1,4-Linked-1,2,3-triazole
Piotr Mucha, Małgorzata Pieszko, Irena Bylińska, et al.
Biomedicines (2024) Vol. 12, Iss. 3, pp. 570-570
Open Access | Times Cited: 1

Targeting Viral Transcription for HIV Cure Strategies
Jon Izquierdo-Pujol, María C. Puertas, Javier Martínez‐Picado, et al.
Microorganisms (2024) Vol. 12, Iss. 4, pp. 752-752
Open Access | Times Cited: 1

The interconnection between periodontitis and HIV-1 latency: Molecular mechanisms and therapeutic insights
Tengyi Zheng, Fangguo Lu, Tiange Cai, et al.
International Immunopharmacology (2024) Vol. 143, pp. 113402-113402
Closed Access | Times Cited: 1

Page 1 - Next Page

Scroll to top